A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Clinical trial NCT06638307 · RECRUITING
Trial details
- NCT number
- NCT06638307
- Sponsor
- Stemline Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-25
- Primary completion
- 2027-10-24
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.